Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1531-1535

  Li, Ping ^a   Zhang, Dianliang ^a   Guo, Chunbao ^b  

^a QINGDAO UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Gastric cancer; Serum proteomic patterns; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERUM; STOMACH CANCER; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEIN ARRAY ANALYSIS; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS;

EID: 84860746012     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.834     Document Type: Article

References (32)

1. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005. (Pubitemid 40165308)
2. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20, 2006.
3. Spataro V, Genoni M, Maurer C and Muller W: Stomach cancer: 10 years' experience with surgical treatment and possibilities for improving the prognosis. Helv Chir Acta 59: 589-595, 1993.
4. Cenitagoya GF, Bergh CK and Klinger-Roitman J: A prospective study of gastric cancer. 'Real' 5-year survival rates and mortality rates in a country with high incidence. Dig Surg 15: 317-322, 1998. (Pubitemid 28395658)
5. Maruyama K, Okabayashi K and Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11: 418-425, 1987. (Pubitemid 17137100)
6. Bunt AM, Hermans J, Smit VT, van de Velde CJ, Fleuren GJ and Bruijn JA: Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 13: 19-25, 1995.
7. Jankowski JA and Odze RD: Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 104: 1093-1096, 2009.
8. Qiu MZ, Lin JZ, Wang ZQ, et al: Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers 24: 258-264, 2009.
9. Marrelli D, Roviello F, De Stefano A, et al: Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 57: 55-62, 1999. (Pubitemid 29308672)
10. Carpelan-Holmstorm M, Louhimo J, Stenman UH, Alfthan H and Haglund C: CEA, CA 19-9 and CA72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 22: 2311-2316, 2002. (Pubitemid 34857058)
11. Adam B-L, Vlahou A, Semmes OJ and Wright GL Jr: Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1: 1264-1270, 2001.
12. Adam B-L, Qu Y, Davis JW, Ward MD, Clements MA and Cazares LH: Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62: 3609-3614, 2002. (Pubitemid 34728833)
13. Fung ET, Weinberger SR, Gavin E and Zhang F: Bioinformatics approaches in clinical proteomics. Expert Rev Proteomics 2: 847-862, 2005. (Pubitemid 41748281)
14. Roboz J: Mass spectrometry in diagnostic oncoproteomics. Cancer Invest 23: 465-478, 2005.
15. Posadas EM, Simpkins F, Liotta LA, MacDonald C and Kohn EC: Proteomic analysis for the early detection and rational treatment of cancer - realistic hope? Ann Oncol 16: 16-22, 2005. (Pubitemid 40124471)
16. Li J, Zhang Z, Rosenzweig J, Wang YY and Chan DW: Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48: 1296-1304, 2002. (Pubitemid 34809839)
17. Clarke CH, Buckley JA and Fung ET: proteomics of breast cancer. Clin Chem Lab Med 43: 1314-1320, 2005.
18. Rui Z, Jian-Guo J, Yuan-Peng T, Hai P and Bing-Gen R: Use of serological proteomic methods to find biomarkers associated with breast cancer. Proteomics 3: 433-439, 2003.
19. Kim J, Kim SH, Lee SU, et al: Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23: 4142-4156, 2002. (Pubitemid 36131469)
20. Zinkin NT, Grall F, Bhaskar K, et al: Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 14: 470-477, 2008. (Pubitemid 351226115)
21. Feng Y, Tian ZM, Wan MX and Zheng ZB: Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis. World J Gastroenterol 13: 2608-2614, 2007. (Pubitemid 46938833)
22. Li C, Chen Z, Xiao Z, et al: Comparative proteomics analysis of human lung squamous carcinoma. Biochem Biophys Res Commun 309: 253-260, 2003. (Pubitemid 36999783)
23. Au JS, Cho WC, Yip TT and Law SC: Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Invest 26: 128-135, 2008. (Pubitemid 351225458)
24. Lin JF, Xu J, Tian HY, et al: Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int J Cancer 121: 2596-2605, 2007. (Pubitemid 350136401)
25. Gagnon A, Kim JH, Schorge JO, et al: Use of a combination of approaches to identify and validate relevant tumorassociated antigens and their corresponding autoantibodies in ovarian cancer patients. Clin Cancer Res 14: 764-771, 2008. (Pubitemid 351231158)
26. Petricoin EF and Liotta LA: Proteomic approaches in cancer risk and response assessment. Trends Mol Med 10: 59-64, 2004. (Pubitemid 38210025)
27. Lu HB, Zhou JH, Ma YY, et al: Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn J Clin Oncol 40: 336-342, 2010.
28. Anderson NL, Matheson AD and Steiner S: Proteomics: applications in basic and applied biology. Curr Opin Biotechnol 11: 408-412, 2000. (Pubitemid 30598936)
29. Ebert MP, Meuer J, Wiemer JC, et al: Identification of gastric cancer patients by serum protein profiling. J Proteome Res 3: 1261-1266, 2004. (Pubitemid 40040381)
30. Liang Y, Fang M, Li J, et al: Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp Mol Pathol 81: 176-180, 2006. (Pubitemid 44780734)
31. Kozak KR, Amneus MW, Pusey SM, et al: Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 100: 12343-12348, 2003. (Pubitemid 37271562)
32. Diamandis EP: Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 96: 353-356, 2004.